Nidhi Subbaraman. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDatabases, FactualDrug Discovery/economicsDrug Industry/economicsEconomics, PharmaceuticalResearch/economics
Year: 2011 PMID: 21552229 DOI: 10.1038/nbt0511-381a
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908